[go: up one dir, main page]

AU8562998A - Idebenone-containing preparation for percutaneous administration - Google Patents

Idebenone-containing preparation for percutaneous administration

Info

Publication number
AU8562998A
AU8562998A AU85629/98A AU8562998A AU8562998A AU 8562998 A AU8562998 A AU 8562998A AU 85629/98 A AU85629/98 A AU 85629/98A AU 8562998 A AU8562998 A AU 8562998A AU 8562998 A AU8562998 A AU 8562998A
Authority
AU
Australia
Prior art keywords
idebenone
containing preparation
percutaneous administration
percutaneous
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU85629/98A
Other languages
English (en)
Inventor
Yasutaka Igari
Yasuyuki Suzuki
Shigeru Toyoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU8562998A publication Critical patent/AU8562998A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AU85629/98A 1997-08-12 1998-08-11 Idebenone-containing preparation for percutaneous administration Abandoned AU8562998A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9-217749 1997-08-12
JP21774997 1997-08-12
PCT/JP1998/003576 WO1999007355A1 (en) 1997-08-12 1998-08-11 Idebenone-containing preparation for percutaneous administration

Publications (1)

Publication Number Publication Date
AU8562998A true AU8562998A (en) 1999-03-01

Family

ID=16709155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU85629/98A Abandoned AU8562998A (en) 1997-08-12 1998-08-11 Idebenone-containing preparation for percutaneous administration

Country Status (2)

Country Link
AU (1) AU8562998A (ja)
WO (1) WO1999007355A1 (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19932197A1 (de) 1999-07-09 2001-01-18 Neudecker Birgit Topisch anzuwendendes Mittel mit schützender und regenerativer Wirkung
MX2007011571A (es) 2005-03-21 2007-12-06 Santhera Pharmaceuticals Ch Derivado de quinona 2,3-dimetoxi-5-metil-6-(10-hidroxidecil)-1,4- benzoquinona para el tratamiento de distrofias musculares.
ATE529104T1 (de) 2008-04-09 2011-11-15 Santhera Pharmaceuticals Ch Idebenon zur behandlung von durch muskuläre dystrophie vermittelten atemwegserkrankungen
EP2246048A1 (en) 2009-04-30 2010-11-03 Santhera Pharmaceuticals (Schweiz) AG Quinone derivative 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of primary progressive multiple sclerosis
EP4121023A1 (en) 2020-03-19 2023-01-25 Bemido SA Idebenone for the treatment of acute respiratory distress syndrome (ards) in patients diagnosed with a coronavirus infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5697223A (en) * 1979-12-30 1981-08-05 Takeda Chem Ind Ltd Tissue metabolism activator
IE62662B1 (en) * 1989-01-06 1995-02-22 Elan Corp Plc Use of nicotine in the treatment of conditions susceptible to said treatment
JPH08768B2 (ja) * 1989-08-24 1996-01-10 武田薬品工業株式会社 神経成長因子分泌誘導剤
GB9205670D0 (en) * 1992-03-16 1992-04-29 Indena Spa New derivatives of physostigmine,their use and pharmaceutical formulations containing them
DE69420776T2 (de) * 1993-06-18 2000-05-18 Takeda Chemical Industries, Ltd. Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer

Also Published As

Publication number Publication date
WO1999007355A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
AU1689999A (en) Medicinal composition for percutaneous administration
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU3992697A (en) Pharmaceutical preparations for intranasal administration
AU1728797A (en) Comforter for delivering medicine
AU7389098A (en) Local anesthetic formulations
AU1267400A (en) Pharmaceutical moxifloxacin preparation
AU2638297A (en) Oral pharmaceutical preparation containing ibandronat
AU6740298A (en) Pharmaceutical composition
AU8667298A (en) Self-binding shearform compositions
AU8107998A (en) Pharmaceutical compositions
AU5495798A (en) External preparations for percutaneous absorption
AU1409100A (en) Drugs
AU8591898A (en) Pharmaceutical compounds
AU3536799A (en) Percutaneous preparations containing oxybutynin
AU5838398A (en) Rapamycin formulations for oral administration
AU4330097A (en) Pharmaceutical compounds
AU9343098A (en) Pharmaceutical composition
AU8562998A (en) Idebenone-containing preparation for percutaneous administration
AU5347996A (en) Preparation for oral administration
AU1414200A (en) Preparations for intraurethral administration
AU6480299A (en) Pharmaceutical compounds
AU1688099A (en) Pharmaceutical preparation
AU1475595A (en) Pharmaceutical preparation
AU6092698A (en) Combination preparation for orally administered antibiotics
AU5182099A (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase